Chicago's Discovery Bid A Defective 'Attack,' Endo Says
By Emily Field · September 7, 2021, 6:52 PM EDT
Endo Pharmaceuticals, which has been facing accusations that it and its lawyers at Arnold & Porter withheld discovery in multidistrict opioid litigation, has told an Illinois federal judge that Chicago's bid...
To view the full article, register now.